Skip to main content
. Author manuscript; available in PMC: 2019 Aug 13.
Published in final edited form as: Am J Perinatol. 2018 Dec 14;36(10):1079–1089. doi: 10.1055/s-0038-1675618

Table 2.

Biomarkers by Race/Ethinicity and Poverty Status, Time 2 and 3, Median (Mean±SD)

A. RACE/ETHNICITY African Americans
(n=1,029)*
Whites
(n=429)
Latinas
(n=450)
Significant Differences**
(p<.05)
Time 2 Time 3 Time 2 Time 3 Time 2 Time 3 Time 2 Time 3
BMI 29.5
(30.9±8.4)
30.0
(30.9±8.8)
26.0
(28.1±7.1)
25.7
(27.6±7.3)
28.0
(28.8±6.0)
27.7
(28.6±6.3)
AA>W,L AA>W,L
Waist-hip ratio 0.86
(0.86±.09)
0.85
(0.86±.09)
0.86
(0.86±.07)
0.86
(0.86±.08)
0.89
(0.89±.07)
0.90
(0.89±.07)
L>AA,W L>AA,W
Systolic BP 113.0
(113.3±12.0)
111.7
(112.7±12.5)
108.7
(109.2±11.5)
109.3
(109.3±10.7)
106.3
(107.4±10.4)
108.7
(109.5±10.9)
AA>W,L AA>W,L
Diastolic BP 74.7
(75.7±10.4)
75.0
(75.1±10.3)
72.0
(72.7±9.0)
71.7
(72.1±9.2)
69.7
(70.1±8.3)
69.0
(70.3±9.0)
AA>W>L AA>W,L
Pulse 78.0
(78.5±10.3)
78.7
(78.5±10.0)
74.3
(74.2±10.9)
74.7
(75.0±11.1)
73.8
(74.6±9.8)
74.7
(75.5±9.3)
AA>W,L AA>W,L
HS-CRP 2.8
(4.2±3.9)
2.8
(4.3±4.3)
2.3
(3.7±3.6)
2.1
(3.8±4.2)
2.7
(4.0±3.5)
2.8
(4.4±4.3)
L>W
Hemoglobin Ale 5.3
(5.4±0.9)
5.3
(5.5±1.1)
5.0
(5.1±0.5)
5.1
(5.1±0.7)
5.4
(5.4±0.6)
5.4
(5.4±0.7)
AA,L>W AA,L>W
HDLcholesterol 40.0
(42.5±14.6)
41.0
(43.3±14.4)
43.0
(45.3±15.9)
42.0
(43.6±14.3)
38.0
(40.6±13.9)
37.0
(40.1±13.6)
W>A A, L AA,W>L
Total-HDLratio 4.2
(4.4±1.7)
3.9
(4.1±1.5)
4.3
(4.4±1.6)
3.9
(4.2±1.5)
4.3
(4.6±1.5)
4.2
(4.5±1.7)
L>AA,W
Cortisol slope −0.02
(−0.02±.03)
n=465
−0.01
(0.02±.02)
n=435
−0.03
(−0.03±.03)
n=262
−0.03
(−0.03±.02)
n=209
−0.02
(−0.02±.02)
n=206
−0.03
(−0.03±.02)
n=188
W,L>AA W,L>AA
B. POVERTY STATUS Poor
(n=816)
Near Poor
(n=529)
Not Poor
(n=563)
Significant Differences (p<.05)
Time 2 Time 3 Time 2 Time 3 Time 2 Time 3 Time 2 Time 3
BMI 29.0
(30.5±8.2)
29.3
(30.5±8.4)
28.9
(29.9±7.5)
28.6
(29.7±7.9)
27.0
(28.5±7.2)
26.0
(28.2±7.4)
Poor,Near>Not Poor,Near>Not
Waist-hip ratio 0.88
(0.88±.09)
0.87
(0.87±.08)
0.87
(0.87±.07)
0.88
(0.88±.08)
0.86
(0.86±.08)
0.85
(0.85±.08)
Poor,Near>Not Poor,Near>Not
Systolic BP 111.7
(111.3±11.6)
110.7
(111.2±12.2)
110.0
(111.0±12.2)
110.3
(111.2±12.0)
109.8
(110.4±11.6)
110.7
(111.1±11.4)
Diastolic BP 73.7
(74.0±10.0)
73.7
(73.9±10.1)
71.7
(73.3±10.3)
71.0
(72.3±10.0)
73.0
(73.5±9.3)
73.3
(73.3±9.7)
Poor > Near
Pulse 78.0
(78.2±10.3)
77.7
(77.9±9.8)
76.7
(76.8±10.5)
76.3
(77.2±10.1)
73.7
(74.0±10.3)
75.3
(75.6±10.7)
Poor,Near>Not Poor > Not
HS-CRP 2.8
(4.2±3.6)
2.9
(4.5±4.3)
2.8
(4.0±3.6)
2.9
(4.5±4.7)
2.3
(3.8±4.0)
2.1
(3.6±3.7)
Poor,Near>Not
Hemoglobin Ale 5.3
(5.3±0.7)
5.3
(5.4±0.9)
5.3
(5.4±0.7)
5.4
(5.4±0.8)
5.2
(5.3±0.8)
5.2
(5.3±1.0)
Poor,Near>Not
HDLcholesterol 40.0
(41.4±14.1)
39.0
(41.1±13.3)
40.0
(42.1±14.3)
41.0
(42.7±13.9)
40.2
(45.2± 16.1)
42.0
(44.6±15.6)
Not>Poor,Near Not > Poor
Total-HDLratio 4.3
(4.5±1.6)
4.0
(4.4±1.6)
4.2
(4.5±1.5)
3.9
(4.1±1.5)
4.0
(4.4±1.7)
3.9
(4.2±1.6)
Cortisol slope −0.02
(−0.02±.03)
n=368
−0.02
(−0.02±.02)
n=336
−0.02
(−0.02±.03)
n=261
−0.02
(−0.02±.02)
n=231
−0.02
(−0.02±.02)
n=304
−0.03
(−0.03±.02)
n=265
Near,Not>Poor
*

N’s vary for specific biomarkers depending on the amount of missing data; see text for details. Sample sizes for most biomarkers were ~70% or more of the total race-specific n’s atthe top of the columns. The exception was cortisol slope, for which n’s are shown separately.

**

StatasticaI significance determine by one-way ANOVA with multiplecomparisons based on t-tests for all biomarkers except those with skewed distributions (HS-CRP, Hemoglobin Ale, and HDL cholesterol), for which significancewas determined by nonparmetric one-way ANOVA with multiple comparisons based on Wilcoxon rank-sum tests.